Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco hires FDA genomics expert

Executive Summary

Felix Frueh joins Medco as VP-R&D, personalized medicine. He had been associate director for genomics in the FDA's Office of Clinical Pharmacology since 2004. While at the agency, Frueh was responsible for developing policy on pharmacogenomics. He also chaired FDA's Interdisciplinary Pharmacogenomics Review Group. In the new position at Medco, he will advance research in genetic testing aimed at improving the precision of pharmacy care and will develop the firm's Personalized Medicine Research Center, under construction in Whitestown, Ind. Medco currently is collaborating with the Mayo Clinic and Lab Corp. on genetic research on improving treatment with warfarin and tamoxifen (1"The Pink Sheet," Nov. 26, 2007, p. 11)
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

PS049645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel